SCHEMBL7325689

SCHEMBL7325689

COC(=O)c1cc(-c2cccnc2)nn1-c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.47
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.45
EPHX2 P34913 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
RECQL P46063 1/20 0.43
GAA P10253 1/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CYP19A1 P11511 2/20 0.43
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
PHGDH O43175 1/20 0.42
USP8 P40818 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7239521 0.87 PKM (0.48) MAPTALDH1A1KDM4ESMN1; SMN2EPHX2
SCHEMBL7328104 0.78 NPY5R (0.53) MAPTALDH1A1SMN1; SMN2CA12CA1
SCHEMBL7236975 0.78 USP8 (0.44) MAPTSMN1; SMN2CA12CA1CA2
SCHEMBL7233236 0.78 USP8 (0.48) MAPTALDH1A1SMN1; SMN2EPHX2CA12
SCHEMBL7315513 0.78 CA1 (0.52) MAPTALDH1A1SMN1; SMN2EPHX2CA12
SCHEMBL7234719 0.78 EPHX2 (0.60) MAPTALDH1A1SMN1; SMN2EPHX2CA12
SCHEMBL7327417 0.77 USP8 (0.46) MAPTALDH1A1SMN1; SMN2CA12CA1
SCHEMBL15070430 0.76 PTGS2 (0.50) MAPTSMN1; SMN2CA12CA1CA2
SCHEMBL7326688 0.76 MAPT (0.40) MAPTALDH1A1SMN1; SMN2EPHX2CA12
SCHEMBL7314318 0.76 USP8 (0.48) MAPTALDH1A1SMN1; SMN2EPHX2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP disclosed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 MAPT 2674/4885ALDH1A1 211/4885KDM4E 2261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.